Crocs (NASDAQ:CROX – Get Free Report) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 2.380-2.520 for the period, compared to the consensus earnings per share estimate of 2.620. The company issued revenue guidance of $905.8 million-$905.8 million, compared to the consensus revenue estimate of $926.3 million. Crocs also updated its FY 2025 guidance to 12.700-13.150 EPS.
Crocs Price Performance
Crocs stock traded up $19.39 during midday trading on Thursday, reaching $108.22. The company’s stock had a trading volume of 5,213,967 shares, compared to its average volume of 1,571,179. The company has a current ratio of 1.43, a quick ratio of 0.90 and a debt-to-equity ratio of 0.82. The stock has a market cap of $6.31 billion, a PE ratio of 7.85, a price-to-earnings-growth ratio of 1.67 and a beta of 1.93. Crocs has a 52 week low of $88.25 and a 52 week high of $165.32. The business has a 50-day moving average price of $105.75 and a 200-day moving average price of $119.68.
Crocs (NASDAQ:CROX – Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The textile maker reported $2.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.25. Crocs had a net margin of 20.50% and a return on equity of 49.70%. On average, sell-side analysts predict that Crocs will post 12.92 EPS for the current year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Crocs
About Crocs
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Recommended Stories
- Five stocks we like better than Crocs
- Energy and Oil Stocks Explained
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 3 Healthcare Dividend Stocks to Buy
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Stock Analyst Ratings and Canadian Analyst Ratings
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.